O	0	7	Effects
O	8	10	of
B-intervention	11	14	Nia
I-intervention	15	23	exercise
O	24	26	in
O	27	32	women
O	33	42	receiving
O	43	52	radiation
O	53	60	therapy
O	61	64	for
O	65	71	breast
O	72	78	cancer
O	78	79	.

O	80	82	To
O	83	90	compare
O	91	92	a
O	93	95	12
O	95	96	-
O	96	100	week
O	101	115	nontraditional
O	116	124	exercise
O	125	128	Nia
O	129	136	program
O	137	146	practiced
O	147	149	at
O	150	154	home
O	155	157	to
O	158	163	usual
O	164	168	care
O	169	171	on
O	172	179	fatigue
O	179	180	,
O	181	188	quality
O	189	191	of
O	192	196	life
O	197	198	(
O	198	201	QOL
O	201	202	)
O	202	203	,
O	204	211	aerobic
O	212	220	capacity
O	220	221	,
O	222	225	and
O	226	234	shoulder
O	235	246	flexibility
O	247	249	in
B-eligibility	250	255	women
I-eligibility	256	260	with
I-eligibility	261	267	breast
I-eligibility	268	274	cancer
I-eligibility	275	285	undergoing
I-eligibility	286	295	radiation
I-eligibility	296	303	therapy
O	303	304	.

O	305	315	Randomized
O	316	324	clinical
O	325	330	trial
O	330	331	.

O	332	337	Large
O	338	347	community
O	347	348	-
O	348	353	based
O	354	362	hospital
O	363	365	in
O	366	369	the
O	370	380	midwestern
B-location	381	387	United
I-location	388	394	States
O	394	395	.

B-total-participants	396	398	41
B-eligibility	399	404	women
I-eligibility	405	409	with
I-eligibility	410	415	stage
I-eligibility	416	417	I
I-eligibility	417	418	,
I-eligibility	419	421	II
I-eligibility	421	422	,
I-eligibility	423	425	or
I-eligibility	426	429	III
I-eligibility	430	436	breast
I-eligibility	437	443	cancer
I-eligibility	444	452	starting
I-eligibility	453	462	radiation
I-eligibility	463	470	therapy
O	470	471	.

B-intervention-participants	472	474	22
O	475	480	women
O	481	485	were
O	486	496	randomized
O	497	499	to
O	500	503	the
O	504	507	Nia
O	508	513	group
O	514	517	and
B-control-participants	518	520	19
O	521	523	to
O	524	527	the
B-control	528	533	usual
I-control	534	538	care
I-control	539	544	group
O	544	545	.

O	546	551	Those
O	552	554	in
O	555	558	the
O	559	562	Nia
O	563	568	group
O	569	573	were
O	574	584	instructed
O	585	587	to
O	588	596	practice
O	597	600	Nia
O	601	603	20
O	603	604	-
O	604	606	60
O	607	614	minutes
O	615	620	three
O	621	626	times
O	627	630	per
O	631	635	week
O	636	639	for
O	640	642	12
O	643	648	weeks
O	648	649	.

O	650	655	Those
O	656	658	in
O	659	662	the
O	663	668	usual
O	669	673	care
O	674	679	group
O	680	684	were
O	685	695	instructed
O	696	698	to
O	699	707	continue
O	708	714	normal
O	715	725	activities
O	725	726	.

O	727	734	Fatigue
O	734	735	,
O	736	739	QOL
O	739	740	,
O	741	748	aerobic
O	749	757	capacity
O	757	758	,
O	759	762	and
O	763	771	shoulder
O	772	783	flexibility
O	783	784	.

B-outcome	785	796	Controlling
I-outcome	797	800	for
I-outcome	801	809	baseline
I-outcome	810	816	scores
O	816	817	,
B-outcome	818	824	change
I-outcome	825	829	over
I-outcome	830	834	time
O	835	842	between
O	843	849	groups
O	850	853	was
O	854	867	significantly
O	868	877	different
O	878	881	for
O	882	885	the
O	886	891	women
O	892	895	who
O	896	905	practiced
O	906	909	Nia
O	910	912	at
O	913	918	least
O	919	921	13
O	922	927	times
O	928	934	during
O	935	938	the
O	939	941	12
O	941	942	-
O	942	946	week
O	947	953	period
O	953	954	;
O	955	960	those
O	961	963	in
O	964	967	the
O	968	971	Nia
O	972	984	intervention
O	985	993	reported
O	994	1007	significantly
O	1008	1012	less
B-outcome	1013	1020	fatigue
O	1021	1028	between
O	1029	1034	weeks
O	1035	1036	6
O	1037	1040	and
O	1041	1043	12
O	1043	1044	,
O	1045	1047	as
O	1048	1056	compared
O	1057	1059	to
O	1060	1067	control
O	1068	1073	group
O	1074	1075	(
O	1075	1076	p
O	1077	1078	=
O	1079	1080	0
O	1080	1081	.
O	1081	1083	05
O	1083	1084	)
O	1084	1085	.

O	1086	1088	No
O	1089	1100	statistical
O	1101	1112	differences
O	1113	1115	in
B-outcome	1116	1119	QOL
O	1119	1120	,
B-outcome	1121	1128	aerobic
I-outcome	1129	1137	capacity
O	1137	1138	,
O	1139	1141	or
B-outcome	1142	1150	shoulder
I-outcome	1151	1162	flexibility
O	1163	1167	were
O	1168	1173	found
O	1173	1174	,
O	1175	1178	but
O	1179	1185	trends
O	1186	1194	favoring
O	1195	1198	Nia
O	1199	1203	were
O	1204	1214	identified
O	1214	1215	.

O	1216	1219	For
O	1220	1225	women
O	1226	1236	undergoing
O	1237	1246	radiation
O	1247	1254	therapy
O	1255	1258	for
O	1259	1265	breast
O	1266	1272	cancer
O	1272	1273	,
O	1274	1277	Nia
O	1278	1281	can
O	1282	1286	help
O	1287	1294	relieve
B-outcome	1295	1302	fatigue
O	1302	1303	.

O	1304	1314	Additional
O	1315	1323	research
O	1324	1326	in
O	1327	1330	arm
O	1331	1334	and
O	1335	1343	shoulder
O	1344	1352	mobility
O	1353	1356	and
O	1357	1369	preservation
O	1370	1374	also
O	1375	1378	may
O	1379	1381	be
O	1382	1392	beneficial
O	1392	1393	.

O	1394	1402	Oncology
O	1403	1409	nurses
O	1410	1413	are
O	1414	1416	in
O	1417	1418	a
O	1419	1425	unique
O	1426	1434	position
O	1435	1437	to
O	1438	1443	offer
O	1444	1455	suggestions
O	1456	1458	to
O	1459	1463	help
O	1464	1470	manage
O	1471	1478	fatigue
O	1478	1479	,
O	1480	1483	and
O	1484	1487	Nia
O	1488	1493	could
O	1494	1496	be
O	1497	1507	considered
O	1508	1510	as
O	1511	1515	part
O	1516	1518	of
O	1519	1520	a
O	1521	1527	cancer
O	1528	1540	survivorship
O	1541	1548	program
O	1548	1549	.

O	1550	1558	Exercise
O	1559	1561	is
O	1562	1572	beneficial
O	1573	1576	for
O	1577	1582	women
O	1583	1587	with
O	1588	1594	breast
O	1595	1601	cancer
O	1601	1602	,
O	1603	1606	and
O	1607	1615	interest
O	1616	1618	is
O	1619	1626	growing
O	1627	1629	in
O	1630	1644	nontraditional
O	1645	1653	exercise
O	1654	1661	options
O	1661	1662	.

O	1663	1666	Nia
O	1667	1670	can
O	1671	1678	benefit
O	1679	1684	women
O	1685	1689	with
O	1690	1696	breast
O	1697	1703	cancer
O	1704	1714	undergoing
O	1715	1724	radiation
O	1725	1732	therapy
O	1732	1733	.
